Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2005-2-1
pubmed:abstractText
Interferon (IFN)-stimulated gene (15 kDa) (ISG15) is a ubiquitin-like protein that forms covalent conjugates with cellular proteins. ISG15 is induced by IFN, microbial challenge, and p53, suggesting that it represents a genetic response that is shared among diverse stress stimuli. To investigate the regulation of this posttranslational modification pathway by a genotoxic chemotherapeutic agent, we examined ISG15 induction and conjugation in cells treated with the topoisomerase I (topoI) poison, camptothecin (CPT). CPT induced ISG15mRNA, and induction required protein synthesis and a functional p53 protein. However, IFN and the Jak-Stat components of the IFN signaling pathway were dispensable for CPT induction of ISG15. CPT induced free ISG15 and conjugates in a dose-dependent and time-dependent manner. A single 55-kDa protein was the prominent CPT-induced ISG15 conjugate and localized to the nuclear compartment. CPT-induced ISG15 conjugates were distinct from those induced by IFN; however, CPT treatment dramatically enhanced ISG15 conjugation in response to IFN. These findings provide the first evidence of a stimulus-specific induction of discrete ISG15 conjugate species and demonstrate that treatment with a combination of cancer therapeutic agents can cooperate to enhance ISG15 conjugation. Identification of the specific ISG15 conjugates induced by chemotherapeutic agents may reveal novel molecular targets.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1079-9907
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
647-54
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15684817-Antineoplastic Agents, Phytogenic, pubmed-meshheading:15684817-Blotting, Northern, pubmed-meshheading:15684817-Blotting, Western, pubmed-meshheading:15684817-Camptothecin, pubmed-meshheading:15684817-Cell Line, Tumor, pubmed-meshheading:15684817-Cell Nucleus, pubmed-meshheading:15684817-Cycloheximide, pubmed-meshheading:15684817-Cytokines, pubmed-meshheading:15684817-Dose-Response Relationship, Drug, pubmed-meshheading:15684817-Humans, pubmed-meshheading:15684817-Interferons, pubmed-meshheading:15684817-Protein Binding, pubmed-meshheading:15684817-Protein Processing, Post-Translational, pubmed-meshheading:15684817-RNA, Messenger, pubmed-meshheading:15684817-Signal Transduction, pubmed-meshheading:15684817-Time Factors, pubmed-meshheading:15684817-Topoisomerase I Inhibitors, pubmed-meshheading:15684817-Ubiquitins
pubmed:year
2004
pubmed:articleTitle
Camptothecin induces the ubiquitin-like protein, ISG15, and enhances ISG15 conjugation in response to interferon.
pubmed:affiliation
Program in Molecular and Cell Biology, University of Maryland, School of Medicine, Baltimore, MD 21201, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't